Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1986 1
1987 2
1988 6
1989 5
1990 4
1991 3
1992 2
1993 6
1994 3
1995 11
1996 7
1997 3
1998 4
1999 6
2000 2
2001 2
2002 6
2003 1
2004 1
2005 2
2006 1
2007 1
2008 1
2009 2
2011 4
2012 4
2013 7
2014 3
2015 5
2016 7
2017 4
2018 9
2019 4
2020 4
2021 6
2022 6
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant trastuzumab in HER2-positive breast cancer.
Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J; Breast Cancer International Research Group. Slamon D, et al. N Engl J Med. 2011 Oct 6;365(14):1273-83. doi: 10.1056/NEJMoa0910383. N Engl J Med. 2011. PMID: 21991949 Free PMC article. Clinical Trial.
The Screening, Diagnosis, Treatment, and Follow-Up of Breast Cancer.
Wöckel A, Albert US, Janni W, Scharl A, Kreienberg R, Stüber T. Wöckel A, et al. Among authors: scharl a. Dtsch Arztebl Int. 2018 May 4;115(18):316-323. doi: 10.3238/arztebl.2018.0316. Dtsch Arztebl Int. 2018. PMID: 29807560 Free PMC article.
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper.
Wörmann B, Bokemeyer C, Burmeister T, Köhne CH, Schwab M, Arnold D, Blohmer JU, Borner M, Brucker S, Cascorbi I, Decker T, de Wit M, Dietz A, Einsele H, Eisterer W, Folprecht G, Hilbe W, Hoffmann J, Knauf W, Kunzmann V, Largiadèr CR, Lorenzen S, Lüftner D, Moehler M, Nöthen MM, Pox C, Reinacher-Schick A, Scharl A, Schlegelberger B, Seufferlein T, Sinn M, Stroth M, Tamm I, Trümper L, Wilhelm M, Wöll E, Hofheinz RD. Wörmann B, et al. Among authors: scharl a. Oncol Res Treat. 2020;43(11):628-636. doi: 10.1159/000510258. Epub 2020 Oct 23. Oncol Res Treat. 2020. PMID: 33099551 Free article. Review.
Financing of certified centers: a willingness-to-pay analysis.
Thiel FC, Scharl A, Hildebrandt T, Kotziabassis E, Schrauder MG, Bani MR, Müller A, Hauzenberger T, Loehberg CR, Jud SM, Fasching PA, Hartmann A, Schulz-Wendtland R, Strnad V, Beckmann MW, Lux MP. Thiel FC, et al. Among authors: scharl a. Arch Gynecol Obstet. 2013 Mar;287(3):495-509. doi: 10.1007/s00404-012-2572-3. Epub 2012 Oct 19. Arch Gynecol Obstet. 2013. PMID: 23080545
Treatment Modification in Young Breast Cancer Patients.
Scharl A, Salterberg A, Untch M, Liedtke C, Stickeler E, Papathemelis T. Scharl A, et al. Oncol Res Treat. 2016;39(3):122-8. doi: 10.1159/000444355. Epub 2016 Feb 24. Oncol Res Treat. 2016. PMID: 27031253 Review.
141 results